Biogen to invest $2 billion in RTP, open new factory in 2025

Biogen Inc. on Monday announced a plan to invest $2 billion to expand manufacturing in Research
Triangle Park (RTP).

The company is marking 30 years at RTP, and will open an eighth state-of-the-art factory in the second half of 2025.

“We are
proud of our longstanding commitment to manufacturing innovation,
investment, and collaboration with the Research Triangle Park
community,” said Nicole Murphy, Biogen head of pharmaceutical operations and technology.

“With
this investment, we will modernize and expand our manufacturing
capability to enable our pipeline and provide resilient patient supply,
while continuing to support the skilled and dedicated community of life
sciences talent in North Carolina.”

Biogen is North Carolina’s largest
biotechnology employer and one of the top five biopharmaceutical
employers in the state, with over 1,500 employees and more than 400 contractors in Wake and Durham counties.